Estrogen receptor mutations linked with worse outcomes in MBC

Estrogen receptor mutations in estrogen receptor–positive metastatic breast cancer are more prevalent than previous studies and methodologies suggest, investigators found during a secondary analysis...
Source: Ob.Gyn. News - Category: OBGYN Source Type: research